Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Cancer therapy developer Orca Bio hopes to turn fresh results from a late-stage clinical trial into regulatory approval next ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

Researchers in China have used the body’s own immune system to kill cancerous cells in a pioneering new therapy.

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

Researchers have discovered that cancer cells suppress 'poison exons' -- genetic elements that act as an off switch for protein production -- in a key gene called TRA2 , promoting tumor growth. By ...

Even cells experience peer pressure. Scientists have long studied the ins and outs of cancer cells to learn more about the ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

Researchers uncover how leukemia drains T cells' energy, paving the way for stronger cancer immunotherapy and enhancing CAR T ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Scientists are using artificial intelligence to better capture how healthy cells surrounding tumors influence cancer cell behavior and how those interactions can inform treatments.